# Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage

> **NCT07642427** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Ganzhou City People's Hospital** · enrollment: 388 (estimated)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage (aSAH)
- Delayed Cerebral Ischemia

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07642427
- **Lead sponsor:** Ganzhou City People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-05
- **Final completion:** 2029-08
- **Target enrollment:** 388 (ESTIMATED)
- **Last updated:** 2026-06-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07642427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07642427, "Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07642427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*